Seatrack International Tradex Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Seatrack International Tradex Private Limited Pharmaceutical Export Portfolio Dataset — 4 Products, $372.3K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Seatrack International Tradex Private Limited — Pharmaceutical Exporter Profile (2026) | 4 Products, $372.3K Trade | TransData Nexus

Seatrack International Tradex Private Limited

Indian Pharmaceutical Exporter · Advanced Oncology Specialist · $372.3K Total Trade · DGFT Verified

Seatrack International Tradex Private Limited is an Indian pharmaceutical exporter with a total trade value of $372.3K across 4 products in 1 therapeutic categories. Based on 53 verified export shipments from Indian Customs (DGFT) records, Seatrack International Tradex Private Limited is the #1 Indian exporter in 1 product including Axitinib. Top exports include Bleomycin ($273.1K), Tofacitinib ($82.4K), Axitinib ($10.8K).

Seatrack International Tradex Private Limited — Export Portfolio & Destination Treemap

Seatrack International Tradex Private Limited pharmaceutical export portfolio — 4 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Seatrack International Tradex Private Limited? — Company Overview & Market Position

Seatrack International Tradex Private Limited, established on April 20, 2019, is a private limited company headquartered in New Delhi, India. The company is registered under the Corporate Identification Number (CIN) U74999DL2019PTC348869 and is classified as a non-government entity. Its authorized share capital is ₹5 million, with a paid-up capital of ₹100,000. The registered office is located at K-72-A Ground Floor, Kalkaji, New Delhi, Delhi, 110019.

The company operates in the infrastructure and utilities sector, focusing on business activities categorized under NIC code 74999, which includes other business activities not elsewhere classified. As of the latest available data, the company has two directors: Susheel Kumar and Shikha Sharma. Susheel Kumar has been serving as a director since April 20, 2019, while Shikha Sharma joined as a director on March 6, 2021.

Financially, Seatrack International Tradex Private Limited has demonstrated significant growth. In the fiscal year ending March 31, 2023, the company reported a 226.77% increase in total revenue compared to the previous year. Profitability also improved, with a 208.67% increase in profit. The net worth of the company saw a substantial rise of 276.79% during the same period.

What Does Seatrack International Tradex Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Bleomycin

Product Portfolio — Top 4 by Export Value

Seatrack International Tradex Private Limited exports 4 pharmaceutical products across 1 therapeutic categories. Market leader (#1 exporter) in 1 products.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Bleomycin	Advanced Oncology	$273.1K	6	4.9%	6
2	Tofacitinib	Advanced Oncology	$82.4K	26	2.1%	5
3	Axitinib	Advanced Oncology	$10.8K	15	11.6%	1
4	Regorafenib	Advanced Oncology	$5.9K	6	0.6%	8

Seatrack International Tradex Private Limited exports 4 pharmaceutical products across 1 therapeutic categories with a total export value of $372.3K. The company is the #1 Indian exporter in 1 product: Axitinib. The top category is Advanced Oncology (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Seatrack International Tradex Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Specific details regarding Seatrack International Tradex Private Limited's manufacturing facilities are not publicly disclosed. The company's registered address is in New Delhi, suggesting that its operations may be centralized in this location. However, without explicit information, it is challenging to provide a comprehensive overview of their manufacturing capabilities, capacities, and specializations.

3Key Leadership

The leadership team of Seatrack International Tradex Private Limited comprises two directors:

Susheel Kumar: Serving as a director since April 20, 2019, Susheel Kumar has been instrumental in steering the company's strategic direction and operations.

Shikha Sharma: Appointed as a director on March 6, 2021, Shikha Sharma brings additional expertise to the leadership team, contributing to the company's growth and development.

The company's leadership has been pivotal in achieving significant financial growth, including a 226.77% increase in total revenue in the fiscal year ending March 31, 2023.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Seatrack International Tradex Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Seatrack International Tradex Private Limited's export activities, as reported by TransData Nexus, indicate a focus on the Advanced Oncology therapeutic category, with a portfolio concentration of 100% in this area. The company's top five exported products include Bleomycin, Tofacitinib, Axitinib, and Regorafenib, all of which are finished pharmaceutical formulations. Notably, Axitinib holds the #1 market position with a 11.6% market share.

While specific regulatory filings and approvals in the US, EU, UK, Australia, and Japan are not detailed in the available data, the company's export activities suggest compliance with international standards. The focus on advanced oncology products indicates adherence to stringent regulatory requirements in these markets. However, without explicit information on regulatory approvals, a comprehensive analysis of the company's presence in these regulated markets cannot be provided.

2Emerging Markets

Seatrack International Tradex Private Limited's export data highlights a strong presence in the Advanced Oncology therapeutic category, with a portfolio concentration of 100% in this area. The company's top five exported products, including Bleomycin, Tofacitinib, Axitinib, and Regorafenib, are finished pharmaceutical formulations, indicating a focus on delivering ready-to-use medications. Notably, Axitinib holds the #1 market position with a 11.6% market share.

Seatrack International Tradex Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Seatrack International Tradex Private Limited's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. The company's export data indicates a focus on finished pharmaceutical formulations in the Advanced Oncology therapeutic category, suggesting compliance with international standards. However, without explicit information on FDA approvals and inspections, a comprehensive assessment of the company's status with the FDA cannot be provided.

2WHO & EU GMP

The available data does not specify whether Seatrack International Tradex Private Limited holds WHO prequalification or EU Good Manufacturing Practice (GMP) certificates. Given the company's focus on advanced oncology products, obtaining such certifications would be beneficial for accessing international markets. However, without explicit information on these certifications, a detailed assessment cannot be provided.

3CDSCO & Indian Regulatory

Seatrack International Tradex Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Seatrack International Tradex Private Limited operates in the competitive oncology pharmaceutical market, focusing on finished formulations such as Bleomycin, Tofacitinib, Axitinib, and Regorafenib. Notably, Axitinib holds the #1 market position with a 11.6% market share. The company's concentration in the Advanced Oncology therapeutic category suggests a strategic focus on this specialized market segment.

While specific competitors are not identified in the available data, the oncology pharmaceutical market is characterized by several established players with diverse product portfolios. Seatrack's emphasis on finished formulations and its market leadership in Axitinib position it as a competitive entity in this sector. However, the company's concentrated product portfolio may expose it to risks associated with market fluctuations in the oncology segment.

2Key Differentiators

Seatrack International Tradex Private Limited's key differentiators include its specialized focus on the Advanced Oncology therapeutic category and its portfolio of finished pharmaceutical formulations. The company's market leadership in Axitinib, with a 11.6% market share, underscores its expertise and competitive positioning in this segment. This specialization allows the company to leverage in-depth knowledge and operational efficiencies within the oncology market.

Strategic Position

Frequently Asked Questions — Seatrack International Tradex Private Limited

How many pharmaceutical products does Seatrack International Tradex Private Limited export from India?

Seatrack International Tradex Private Limited exports 4 pharmaceutical products across 1 therapeutic categories. The top exports are Bleomycin ($273.1K), Tofacitinib ($82.4K), Axitinib ($10.8K), Regorafenib ($5.9K). Total export value is $372.3K.

What is Seatrack International Tradex Private Limited's total pharmaceutical export value?

Seatrack International Tradex Private Limited's total pharmaceutical export value is $372.3K, based on 53 verified shipments recorded in Indian Customs (DGFT) data.

In which products is Seatrack International Tradex Private Limited the #1 Indian exporter?

Seatrack International Tradex Private Limited is the #1 Indian exporter in 1 products: Axitinib (11.6% market share).

What therapeutic categories does Seatrack International Tradex Private Limited cover?

Seatrack International Tradex Private Limited exports across 1 therapeutic categories. The largest are Advanced Oncology (100.0%, 4 products).

Get Full Seatrack International Tradex Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.